About Ariosa Diagnostics
Ariosa Diagnostics is a company based in San Jose (United States) founded in 2008 was acquired by Roche in December 2014.. Ariosa Diagnostics has raised $67.5 million across 3 funding rounds from investors including Roche and Venrock. The company has 246 employees as of December 31, 2014. Ariosa Diagnostics operates in a competitive market with competitors including Natera, BillionToOne, Progenity, SYNLAB and Beikang Medical, among others.
- Headquarter San Jose, United States
- Employees 246 as on 31 Dec, 2014
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ariosa Diagnostics Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ariosa Diagnostics
Ariosa Diagnostics has successfully raised a total of $67.5M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $52.7 million completed in November 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $52.7M
-
First Round
First Round
(31 Jan 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2011 | Amount | Series C - Ariosa Diagnostics | Valuation |
investors |
|
| May, 2010 | Amount | Series B - Ariosa Diagnostics | Valuation |
investors |
|
| Jan, 2009 | Amount | Series A - Ariosa Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ariosa Diagnostics
Ariosa Diagnostics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche and Venrock. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location | |
|
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ariosa Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ariosa Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ariosa Diagnostics Comparisons
Competitors of Ariosa Diagnostics
Ariosa Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, BillionToOne, Progenity, SYNLAB and Beikang Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
|
| domain | founded_year | HQ Location |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| domain | founded_year | HQ Location |
Provider of medical diagnosis and clinical laboratory analysis services
|
|
| domain | founded_year | HQ Location |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive prenatal genetic tests and genomic services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ariosa Diagnostics
When was Ariosa Diagnostics founded?
Ariosa Diagnostics was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Where is Ariosa Diagnostics located?
Ariosa Diagnostics is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Is Ariosa Diagnostics a funded company?
Ariosa Diagnostics is a funded company, having raised a total of $67.5M across 3 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Jan 31, 2009.
How many employees does Ariosa Diagnostics have?
As of Dec 31, 2014, the latest employee count at Ariosa Diagnostics is 246.
What does Ariosa Diagnostics do?
Ariosa Diagnostics was founded in 2008 in San Jose, United States, focusing on the molecular diagnostics sector. Operations are conducted through a CLIA-certified laboratory, where cell-free DNA in maternal blood is analyzed for prenatal risk assessment. The Harmony Prenatal Test, available from 10 weeks of pregnancy, evaluates risks of trisomies 13, 18, and 21. Acquisition by Roche occurred in December 2014.
Who are the top competitors of Ariosa Diagnostics?
Ariosa Diagnostics's top competitors include Natera, BillionToOne and Pictor.